Scott K Angell, MD
Urology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Angell’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G77581 · Current
Licensed to practise in California · since 1993 · expires 2027-02-28 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$188,184
Medicare paid this office $188,184 for 409 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of bladder and urethra using an endoscope | 138 | $50,429 | $241 |
| Return visit (30+ min) | 126 | $15,601 | $108 |
| New patient visit (45+ min) | 95 | $13,113 | $138 |
| Short return visit (20+ min) | 112 | $12,004 | $78 |
| Biopsy of prostate gland | 45 | $10,126 | $225 |
See all 17 services
| Diagnostic exam of bladder and urethra using an endoscope | 138 | $50,429 | $241 |
| Return visit (30+ min) | 126 | $15,601 | $108 |
| New patient visit (45+ min) | 95 | $13,113 | $138 |
| Short return visit (20+ min) | 112 | $12,004 | $78 |
| Biopsy of prostate gland | 45 | $10,126 | $225 |
| Ultrasound scan of pelvic region through rectum | 68 | $10,125 | $145 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 23 | $7,977 | $332 |
| New patient visit (30+ min) | 79 | $7,893 | $100 |
| Long return visit (40+ min) | 43 | $7,710 | $161 |
| Shock wave crushing of kidney stones | 13 | $7,165 | $551 |
| New patient visit (60+ min) | 14 | $2,643 | $189 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 11 | $2,563 | $214 |
| Simple insertion of temporary bladder tube | 19 | $1,761 | $59 |
| Ultrasound measurement of bladder capacity after voiding | 114 | $1,598 | $12 |
| Insertion of stent in ureter using an endoscope | 11 | $1,105 | $92 |
| Review by radiologist of ureter or urethra image | 28 | $1,051 | $35 |
| Instillation of anti-cancer drug into bladder | 11 | $209 | $19 |
Procedures Medicare counted
| Prostate resection | 37 | More than 94% of doctors who do this |
Who their Medicare patients are
409 Original Medicare patients in 2024. Average age 77 · Women 20% · Also on Medicaid 8% · Health risk score 0.94. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 68% · Cancer 30% · Chronic kidney disease 25% · Diabetes 23% · Coronary heart disease 23% · Atrial fibrillation 19% · Depression 14% · Heart failure 10% · COPD 7% · Stroke 6% · Dementia 5%.
The office billed $921,008, Medicare allowed $249,749 and paid $188,184; for 1,247 services of 59 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 409 | 1,247 | 77 | 0.94 | $921,008 | $188,184 |
| 2023 | 371 | 1,015 | 76 | 1.01 | $683,239 | $150,884 |
| 2022 | 479 | 1,354 | 77 | 0.99 | $934,407 | $207,708 |
| 2021 | 525 | 1,436 | 77 | 0.99 | $920,315 | $218,651 |
| 2020 | 493 | 1,396 | 76 | 1.05 | $967,605 | $200,318 |
| 2019 | 417 | 1,049 | 76 | 1.05 | $687,911 | $136,545 |
| 2018 | 329 | 1,012 | 76 | 1.08 | $578,943 | $106,853 |
| 2017 | 405 | 1,245 | 75 | 1.10 | $673,374 | $123,898 |
| 2016 | 422 | 1,140 | 75 | 1.11 | $674,682 | $138,449 |
| 2015 | 426 | 1,113 | 75 | 1.12 | $702,883 | $148,105 |
| 2014 | 381 | 946 | 76 | 1.08 | $643,770 | $125,040 |
| 2013 | 330 | 974 | 75 | 1.06 | $728,603 | $140,027 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Diagnostic exam of bladder and urethra using an endoscope | 112 | $43,480 | $247 |
| Return visit (30+ min) | 107 | $13,309 | $112 |
| Short return visit (20+ min) | 118 | $12,636 | $77 |
| New patient visit (45+ min) | 78 | $10,124 | $130 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 20 | $8,525 | $426 |
| Biopsy of prostate gland | 31 | $7,189 | $232 |
| Ultrasound scan of pelvic region through rectum | 43 | $6,599 | $150 |
| Long return visit (40+ min) | 31 | $5,256 | $170 |
| New patient visit (30+ min) | 42 | $4,213 | $100 |
| Simple insertion of temporary bladder tube | 17 | $2,069 | $54 |
| Ultrasound measurement of bladder capacity after voiding | 94 | $1,107 | $11 |
| Review by radiologist of ureter or urethra image | 20 | $872 | $36 |
2022: 15 services
| Diagnostic exam of bladder and urethra using an endoscope | 130 | $50,221 | $252 |
| New patient visit (45+ min) | 145 | $20,849 | $144 |
| Return visit (30+ min) | 141 | $17,497 | $108 |
| Short return visit (20+ min) | 133 | $14,173 | $77 |
| Ultrasound scan of pelvic region through rectum | 67 | $10,220 | $150 |
| Biopsy of prostate gland | 40 | $9,370 | $234 |
| Shock wave crushing of kidney stones | 14 | $8,290 | $592 |
| Partial removal of prostate (retropubic) | 13 | $7,962 | $612 |
| Long return visit (40+ min) | 42 | $7,262 | $169 |
| New patient visit (30+ min) | 54 | $5,336 | $99 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 13 | $4,833 | $372 |
| Simple insertion of temporary bladder tube | 26 | $3,670 | $55 |
| Ultrasound measurement of bladder capacity after voiding | 128 | $1,570 | $11 |
| Insertion of stent in ureter using an endoscope | 14 | $1,268 | $85 |
| Review by radiologist of ureter or urethra image | 18 | $688 | $36 |
2021: 13 services
| Diagnostic exam of bladder and urethra using an endoscope | 132 | $44,250 | $240 |
| New patient visit (45+ min) | 184 | $27,114 | $147 |
| Return visit (30+ min) | 141 | $19,459 | $112 |
| Long return visit (40+ min) | 90 | $16,344 | $170 |
| Biopsy of prostate gland | 57 | $14,510 | $255 |
| Ultrasound scan of pelvic region through rectum | 72 | $10,934 | $152 |
| New patient visit (60+ min) | 53 | $10,179 | $192 |
| Short return visit (20+ min) | 84 | $9,198 | $81 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $5,871 | $367 |
| Simple insertion of temporary bladder tube | 29 | $4,101 | $64 |
| New patient visit (30+ min) | 25 | $2,262 | $90 |
| Ultrasound measurement of bladder capacity after voiding | 178 | $2,233 | $11 |
| Review by radiologist of ureter or urethra image | 14 | $553 | $37 |
2020: 15 services
| Diagnostic exam of bladder and urethra using an endoscope | 157 | $43,492 | $212 |
| New patient visit (30+ min) | 219 | $20,590 | $94 |
| Return visit (30+ min) | 178 | $20,196 | $94 |
| Biopsy of prostate gland | 59 | $13,824 | $234 |
| Ultrasound scan of pelvic region through rectum | 80 | $12,933 | $156 |
| Shock wave crushing of kidney stones | 19 | $12,264 | $613 |
| Insertion of needle or tube into prostate for radiation therapy | 11 | $8,118 | $738 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 12 | $8,041 | $670 |
| Short return visit (20+ min) | 74 | $6,271 | $67 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 13 | $4,952 | $381 |
| Simple insertion of temporary bladder tube | 31 | $3,720 | $56 |
| Ultrasound measurement of bladder capacity after voiding | 151 | $1,846 | $11 |
| Insertion of stent in ureter using an endoscope | 17 | $1,637 | $82 |
| Short return visit | 17 | $681 | $36 |
| Injection procedure for imaging of bladder during voiding | 11 | $228 | $21 |
2019: 12 services
| Diagnostic exam of bladder and urethra using an endoscope | 108 | $26,665 | $183 |
| New patient visit (30+ min) | 185 | $17,235 | $93 |
| Return visit (30+ min) | 118 | $13,622 | $99 |
| Ultrasound scan of pelvic region through rectum | 76 | $10,300 | $130 |
| Biopsy of prostate gland | 41 | $9,725 | $237 |
| Shock wave crushing of kidney stones | 15 | $9,093 | $606 |
| Short return visit (20+ min) | 66 | $4,230 | $58 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 11 | $3,251 | $296 |
| Simple insertion of temporary bladder tube | 27 | $3,007 | $58 |
| Ultrasound measurement of bladder capacity after voiding | 130 | $2,009 | $13 |
| Insertion of stent in ureter using an endoscope | 14 | $1,878 | $110 |
| Short return visit | 32 | $1,296 | $37 |
2018: 11 services
| Diagnostic exam of bladder and urethra using an endoscope | 96 | $20,719 | $148 |
| New patient visit (30+ min) | 150 | $13,274 | $88 |
| Return visit (30+ min) | 80 | $8,578 | $94 |
| Biopsy of prostate gland | 25 | $5,823 | $233 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 15 | $5,580 | $328 |
| Ultrasound scan of pelvic region through rectum | 42 | $4,278 | $97 |
| Short return visit (20+ min) | 49 | $3,457 | $63 |
| Simple insertion of temporary bladder tube | 18 | $1,418 | $49 |
| Ultrasound measurement of bladder capacity after voiding | 82 | $1,388 | $16 |
| Insertion of stent in ureter using an endoscope | 12 | $1,284 | $99 |
| Short return visit | 24 | $974 | $35 |
2017: 13 services
| Diagnostic exam of bladder and urethra using an endoscope | 119 | $23,875 | $146 |
| New patient visit (30+ min) | 180 | $16,055 | $89 |
| Shock wave crushing of kidney stones | 19 | $12,487 | $624 |
| Biopsy of prostate gland | 32 | $7,372 | $230 |
| Return visit (30+ min) | 66 | $6,908 | $93 |
| Ultrasound scan of pelvic region through rectum | 58 | $5,748 | $94 |
| New patient visit (45+ min) | 36 | $4,681 | $130 |
| Short return visit (20+ min) | 62 | $4,434 | $61 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 12 | $3,602 | $300 |
| Simple insertion of temporary bladder tube | 20 | $2,867 | $56 |
| Ultrasound measurement of bladder capacity after voiding | 115 | $2,486 | $19 |
| Ultrasonic guidance for needle placement | 32 | $1,886 | $59 |
| Short return visit | 39 | $1,451 | $34 |
2016: 13 services
| Diagnostic exam of bladder and urethra using an endoscope | 134 | $34,849 | $189 |
| New patient visit (30+ min) | 241 | $22,302 | $93 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 14 | $10,430 | $745 |
| Shock wave crushing of kidney stones | 15 | $8,969 | $561 |
| Return visit (30+ min) | 85 | $8,737 | $90 |
| Ultrasound scan of pelvic region through rectum | 62 | $5,619 | $91 |
| Biopsy of prostate gland | 28 | $5,514 | $197 |
| Short return visit (20+ min) | 66 | $4,844 | $65 |
| Simple insertion of temporary bladder tube | 22 | $2,971 | $63 |
| Ultrasound measurement of bladder capacity after voiding | 139 | $2,964 | $19 |
| Short return visit | 46 | $1,591 | $33 |
| Ultrasonic guidance for needle placement | 27 | $1,589 | $59 |
| Insertion of stent in ureter using an endoscope | 11 | $949 | $86 |
2015: 12 services
| Diagnostic exam of bladder and urethra using an endoscope | 113 | $31,207 | $196 |
| New patient visit (30+ min) | 220 | $21,736 | $99 |
| Return visit (30+ min) | 99 | $10,751 | $95 |
| Shock wave crushing of kidney stones | 17 | $10,421 | $579 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 13 | $10,261 | $789 |
| Ultrasound scan of pelvic region through rectum | 56 | $5,363 | $91 |
| Short return visit (20+ min) | 71 | $5,173 | $65 |
| Biopsy of prostate gland | 25 | $5,117 | $205 |
| Simple insertion of temporary bladder tube | 23 | $3,340 | $70 |
| Ultrasound measurement of bladder capacity after voiding | 134 | $3,030 | $20 |
| Short return visit | 44 | $1,830 | $37 |
| Ultrasonic guidance for needle placement | 25 | $1,583 | $61 |
2014: 12 services
| Diagnostic exam of bladder and urethra using an endoscope | 91 | $24,146 | $184 |
| New patient visit (30+ min) | 193 | $17,641 | $91 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 14 | $10,607 | $758 |
| Shock wave crushing of kidney stones | 12 | $8,977 | $641 |
| Return visit (30+ min) | 71 | $7,391 | $95 |
| Ultrasound scan of pelvic region through rectum | 54 | $5,164 | $92 |
| Biopsy of prostate gland | 24 | $4,529 | $189 |
| Short return visit (20+ min) | 62 | $4,303 | $62 |
| Simple insertion of temporary bladder tube | 25 | $2,741 | $65 |
| Ultrasound measurement of bladder capacity after voiding | 112 | $2,436 | $19 |
| Ultrasonic guidance for needle placement | 24 | $1,726 | $72 |
| Short return visit | 36 | $1,494 | $35 |
2013: 15 services
| Diagnostic exam of bladder and urethra using an endoscope | 81 | $21,601 | $183 |
| New patient visit (30+ min) | 143 | $13,656 | $95 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 17 | $12,102 | $712 |
| Shock wave crushing of kidney stones | 19 | $10,641 | $532 |
| Return visit (30+ min) | 81 | $8,557 | $93 |
| Ultrasonic guidance for needle placement | 33 | $7,264 | $214 |
| Biopsy of prostate gland | 32 | $6,622 | $201 |
| Ultrasound scan of pelvic region through rectum | 65 | $4,670 | $70 |
| Short return visit (20+ min) | 55 | $4,358 | $63 |
| Crushing of stone of ureter using an endoscope | 11 | $3,638 | $303 |
| Simple insertion of temporary bladder tube | 18 | $3,530 | $67 |
| New patient visit (45+ min) | 24 | $3,412 | $142 |
| Ultrasound measurement of bladder capacity after voiding | 99 | $2,369 | $20 |
| Insertion of stent in ureter using an endoscope | 16 | $1,382 | $73 |
| Short return visit | 24 | $970 | $37 |
Drugs they prescribed that Part D paid
$24,878
Pharmacies billed $24,878 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 12% of their Part D prescriptions (95 of 795) in 2024. A higher opioid share than 9 in 10 peers; the typical urology clinician is at 2%.
772 generic and 23 brand-name prescriptions · $24,878 in drug cost · 307 antibiotic prescriptions to 171 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 17 | $9,571 | $563 |
| Potassium Citrate Er | 20 | $4,819 | $241 |
| Tamsulosin | 249 | $4,347 | $17 |
| Hydrocodone-Acetaminophen | 92 | $669 | $7 |
| Doxazosin Mesylate | 33 | $482 | $15 |
See all 10 drugs
| Myrbetriq | 17 | $9,571 | $563 |
| Potassium Citrate Er | 20 | $4,819 | $241 |
| Tamsulosin | 249 | $4,347 | $17 |
| Hydrocodone-Acetaminophen | 92 | $669 | $7 |
| Doxazosin Mesylate | 33 | $482 | $15 |
| Sulfamethoxazole-Trimethoprim | 127 | $462 | $4 |
| Finasteride | 22 | $327 | $15 |
| Sildenafil Citrate | 12 | $221 | $18 |
| Ciprofloxacin | 82 | $213 | $3 |
| Cephalexin | 82 | $166 | $2 |
Year by year
| 2024 | 795 | 276 | 12% (95) | 3% | $24,878 |
| 2023 | 665 | 233 | 10% (63) | None | $20,978 |
| 2022 | 792 | 280 | 10% (79) | 1% | $23,422 |
| 2021 | 942 | 305 | 10% (96) | 1% | $28,895 |
| 2020 | 866 | 293 | 11% (94) | 3% | $30,692 |
| 2019 | 584 | 211 | 11% (66) | 4% | $27,042 |
| 2018 | 505 | 178 | 11% (56) | 3% | $30,694 |
| 2017 | 546 | 197 | 9% (47) | None | $31,706 |
| 2016 | 596 | 209 | 12% (72) | 11% | $33,391 |
| 2015 | 572 | 193 | 14% (78) | 12% | $47,636 |
| 2014 | 473 | 157 | 14% (68) | 18% | $45,125 |
| 2013 | 614 | 197 | 14% (84) | None | $28,694 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Potassium Citrate Er | 21 | $6,915 | $329 |
| Tamsulosin | 248 | $6,135 | $25 |
| Doxazosin Mesylate | 37 | $969 | $26 |
| Finasteride | 26 | $628 | $24 |
| Sulfamethoxazole-Trimethoprim | 97 | $449 | $5 |
| Hydrocodone-Acetaminophen | 58 | $371 | $6 |
| Ciprofloxacin | 67 | $324 | $5 |
| Cephalexin | 50 | $210 | $4 |
2022: 12 drugs
| Potassium Citrate Er | 18 | $6,191 | $344 |
| Tamsulosin | 274 | $5,694 | $21 |
| Doxazosin Mesylate | 57 | $1,474 | $26 |
| Dutasteride | 11 | $1,114 | $101 |
| Bicalutamide | 18 | $430 | $24 |
| Sulfamethoxazole-Trimethoprim | 103 | $400 | $4 |
| Hydrocodone-Acetaminophen | 76 | $368 | $5 |
| Finasteride | 23 | $326 | $14 |
| Cephalexin | 66 | $271 | $4 |
| Ciprofloxacin | 66 | $239 | $4 |
| Oxybutynin Chloride | 14 | $205 | $15 |
| Levofloxacin | 11 | $89 | $8 |
2021: 10 drugs
| Potassium Citrate Er | 19 | $9,019 | $475 |
| Tamsulosin | 311 | $5,624 | $18 |
| Doxazosin Mesylate | 65 | $1,712 | $26 |
| Oxybutynin Chloride Er | 24 | $711 | $30 |
| Hydrocodone-Acetaminophen | 94 | $685 | $7 |
| Oxybutynin Chloride | 16 | $626 | $39 |
| Sulfamethoxazole-Trimethoprim | 123 | $563 | $5 |
| Finasteride | 25 | $521 | $21 |
| Ciprofloxacin | 102 | $326 | $3 |
| Cephalexin | 102 | $212 | $2 |
2020: 10 drugs
| Potassium Citrate Er | 23 | $11,487 | $499 |
| Tamsulosin | 240 | $3,844 | $16 |
| Doxazosin Mesylate | 78 | $2,785 | $36 |
| Oxybutynin Chloride Er | 32 | $1,691 | $53 |
| Oxybutynin Chloride | 18 | $659 | $37 |
| Hydrocodone-Acetaminophen | 92 | $513 | $6 |
| Sulfamethoxazole-Trimethoprim | 133 | $491 | $4 |
| Ciprofloxacin | 86 | $301 | $4 |
| Cephalexin | 82 | $257 | $3 |
| Finasteride | 15 | $254 | $17 |
2019: 8 drugs
| Potassium Citrate Er | 19 | $10,276 | $541 |
| Doxazosin Mesylate | 80 | $2,746 | $34 |
| Tamsulosin | 129 | $2,217 | $17 |
| Oxybutynin Chloride Er | 11 | $781 | $71 |
| Sulfamethoxazole-Trimethoprim | 102 | $510 | $5 |
| Hydrocodone-Acetaminophen | 64 | $415 | $6 |
| Ciprofloxacin | 62 | $382 | $6 |
| Cephalexin | 63 | $325 | $5 |
2018: 9 drugs
| Potassium Citrate Er | 20 | $12,685 | $634 |
| Doxazosin Mesylate | 86 | $3,241 | $38 |
| Tamsulosin | 85 | $1,958 | $23 |
| Allopurinol | 18 | $392 | $22 |
| Hydrocodone-Acetaminophen | 53 | $375 | $7 |
| Sulfamethoxazole-Trimethoprim | 96 | $342 | $4 |
| Cephalexin | 37 | $248 | $7 |
| Terazosin | 27 | $175 | $6 |
| Ciprofloxacin | 40 | $164 | $4 |
2017: 11 drugs
| Potassium Citrate Er | 16 | $9,606 | $600 |
| Vesicare | 15 | $8,606 | $574 |
| Doxazosin Mesylate | 107 | $3,096 | $29 |
| Tamsulosin | 88 | $2,716 | $31 |
| Ciprofloxacin | 104 | $380 | $4 |
| Allopurinol | 13 | $330 | $25 |
| Imipramine | 13 | $264 | $20 |
| Hydrocodone-Acetaminophen | 45 | $264 | $6 |
| Cephalexin | 47 | $150 | $3 |
| Sulfamethoxazole-Trimethoprim | 42 | $144 | $3 |
| Terazosin | 11 | $107 | $10 |
2016: 11 drugs
| Vesicare | 29 | $13,978 | $482 |
| Potassium Citrate Er | 13 | $3,739 | $288 |
| Doxazosin Mesylate | 127 | $3,526 | $28 |
| Tamsulosin | 59 | $1,811 | $31 |
| Oxybutynin Chloride Er | 18 | $1,132 | $63 |
| Ciprofloxacin | 152 | $762 | $5 |
| Hydrocodone-Acetaminophen | 72 | $751 | $10 |
| Allopurinol | 19 | $525 | $28 |
| Imipramine | 13 | $318 | $24 |
| Cephalexin | 41 | $135 | $3 |
| Sulfamethoxazole-Trimethoprim | 12 | $44 | $4 |
2015: 11 drugs
| Vesicare | 29 | $8,949 | $309 |
| Potassium Citrate Er | 18 | $6,406 | $356 |
| Doxazosin Mesylate | 113 | $3,312 | $29 |
| Tamsulosin | 71 | $2,362 | $33 |
| Oxybutynin Chloride Er | 22 | $1,657 | $75 |
| Hydrocodone-Acetaminophen | 77 | $674 | $9 |
| Imipramine | 16 | $486 | $30 |
| Ciprofloxacin | 127 | $456 | $4 |
| Allopurinol | 13 | $302 | $23 |
| Cephalexin | 38 | $89 | $2 |
| Sulfamethoxazole-Trimethoprim | 11 | $55 | $5 |
2014: 9 drugs
| Vesicare | 49 | $11,745 | $240 |
| Potassium Citrate Er | 15 | $3,479 | $232 |
| Doxazosin Mesylate | 118 | $3,144 | $27 |
| Tamsulosin | 30 | $800 | $27 |
| Hydrocodone-Acetaminophen | 56 | $452 | $8 |
| Ciprofloxacin | 93 | $371 | $4 |
| Allopurinol | 11 | $199 | $18 |
| Acetaminophen-Codeine | 12 | $105 | $9 |
| Cephalexin | 33 | $86 | $3 |
2013: 11 drugs
| Vesicare | 38 | $9,134 | $240 |
| Potassium Citrate | 11 | $2,725 | $248 |
| Doxazosin Mesylate | 153 | $2,175 | $14 |
| Oxybutynin Chloride Er | 11 | $892 | $81 |
| Ciprofloxacin | 144 | $566 | $4 |
| Tamsulosin | 17 | $474 | $28 |
| Hydrocodone-Acetaminophen | 79 | $367 | $5 |
| Oxybutynin Chloride | 11 | $230 | $21 |
| Allopurinol | 13 | $151 | $12 |
| Cephalexin | 55 | $145 | $3 |
| Sulfamethoxazole-Trimethoprim | 15 | $85 | $6 |
Professional record
- NPI
- 1720175425
- Licence
- CA G77581California G77581: Current · expires 2027-02-28
- Trained
- Stanford University School of Medicine, 1992
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-10-06
- NPI last updated
- 2011-12-07
This is when the NPI record was last certified, not a medical board exam.